Favorskii rearrangement of 23-oxo-3-epi-SMILAGENIN (cas 126-18-1) acetate induced by iodosobenzene
-
Add time:10/01/2019 Source:sciencedirect.com
Treatment of (25R)-3α-acetoxy-5β-spirostan-23-one with diacetoxyiodobenzene in KOH/MeOH led to F-ring contraction via Favorskii rearrangement.
We also recommend Trading Suppliers and Manufacturers of SMILAGENIN (cas 126-18-1). Pls Click Website Link as below: cas 126-18-1 suppliers
Prev:Neurodegeneration, Neuroprotection, and Disease-Oriented NeuroscienceResearch PaperSMILAGENIN (cas 126-18-1) attenuates beta amyloid (25–35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor
Next:Research paperSynthesis of new Sarsasapogenin (cas 126-19-2) derivatives with cytotoxicity and apoptosis-inducing activities in human breast cancer MCF-7 cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Neurodegeneration, Neuroprotection, and Disease-Oriented NeuroscienceResearch PaperSMILAGENIN (cas 126-18-1) attenuates beta amyloid (25–35)-induced degeneration of neuronal cells via stimulating the gene expression of brain-derived neurotrophic factor09/27/2019
- Epi-Sarsasapogenin and epi-SMILAGENIN (cas 126-18-1): two sapogenins isolated from the rumen content of sheep intoxicated by Brachiaria decumbens09/26/2019
- Role of glial cell derived neurotrophic factor in the protective effect of SMILAGENIN (cas 126-18-1) on rat mesencephalic dopaminergic neurons damaged by MPP+09/25/2019
- Regulation of M1-receptor mRNA stability by SMILAGENIN (cas 126-18-1) and its significance in improving memory of aged rats09/24/2019
- Reversal of dopamine neurons and locomotor ability degeneration in aged rats with SMILAGENIN (cas 126-18-1)09/10/2019
- Synthesis and biological evaluation of 3-carbamate SMILAGENIN (cas 126-18-1) derivatives as potential neuroprotective agents09/09/2019
